Private Advisor Group’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.7M Buy
+5,752
New +$1.52M 0.01% 1309
2024
Q4
– Sell
-1,767
Closed -$348K – 2325
2024
Q3
$348K Sell
1,767
-211
-11% -$43.8K ﹤0.01% 1841
2024
Q2
$409K Buy
1,978
+273
+16% +$61.9K ﹤0.01% 1676
2024
Q1
$462K Buy
1,705
+23
+1% +$5.49K ﹤0.01% 1570
2023
Q4
$398K Buy
+1,682
New +$331K ﹤0.01% 1606
2022
Q3
– Sell
-1,370
Closed -$293K – 1963
2022
Q2
$293K Buy
1,370
+39
+3% +$9.5K ﹤0.01% 1658
2022
Q1
$378K Buy
1,331
+178
+15% +$54.9K ﹤0.01% 1550
2021
Q4
$434K Sell
1,153
-15,780
-93% -$6.13M ﹤0.01% 1518
2021
Q3
$6.99M Buy
16,933
+7,878
+87% +$3.27M 0.04% 406
2021
Q2
$3.35M Buy
9,055
+557
+7% +$186K 0.03% 554
2021
Q1
$2.46M Sell
8,498
-1,143
-12% -$318K 0.02% 625
2020
Q4
$2.41M Buy
+9,641
New +$2.3M 0.03% 600
2020
Q3
– Sell
-256
Closed -$45K – 1929
2020
Q2
$45K Buy
+256
New +$40.9K ﹤0.01% 2157
2017
Q2
– Sell
-32,742
Closed -$769K – 1397
2017
Q1
$769K Buy
+32,742
New +$2.78M 0.02% 624
2014
Q4
– Sell
-5,567
Closed -$333K – 1041
2014
Q3
$333K Hold
5,567
– – 0.02% 659
2014
Q2
$298K Buy
+5,567
New +$305K 0.03% 656

Other funds holding CRL

Private Advisor Group's CRL Position: Q3 2026 in Review

Private Advisor Group opened a new position in Charles River Laboratories (CRL) in Q3 2026: 5,752 shares worth $1.7M. The stake represents 0.01% of the portfolio and ranks #1309 among its holdings. This is a return to the name: Private Advisor Group previously reported a position in CRL as recently as Q3 2024.

Private Advisor Group first reported a position in CRL in Q2 2014 and has held it in 16 quarters since. The position peaked at $6.99M in Q3 2021. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Private Advisor Group held 5,752 shares of Charles River Laboratories worth $1.7M as of Q3 2026.
  • Charles River Laboratories was a new Private Advisor Group position in Q3 2026.
  • Charles River Laboratories made up 0.01% of Private Advisor Group's portfolio in Q3 2026, its #1309 holding.
  • Private Advisor Group first reported a position in Charles River Laboratories in Q2 2014 and has held it in 16 quarters since.
  • Private Advisor Group's Charles River Laboratories position peaked at $6.99M in Q3 2021.
  • 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.